TNK2 and prostate cancer: To further validate ACK1/SHP2/AR/pY54-H3 signaling, AR expressing prostate cancer cells were transfected with siRNAs; a significant build-up of pY54-H3 levels was seen upon ACK1, SHP2 or AR knockdown (Fig. 2d).